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Alzheimers disease (AD) is the most common cause of dementia. Although the underlying
pathology is still not completely understood, several diagnostic methods are available.
Frequently, the most accurate methods are also the most invasive. The present work
investigates the diagnostic potential of Pulsed Arterial Spin Labeling (PASL) for AD: a
non-invasive, MRI-based technique for the quantification of regional cerebral blood flow
(rCBF). In particular, we propose a pilot computer aided diagnostic (CAD) procedure able
to discriminate between healthy and diseased subjects, and at the same time, providing
visual informative results. This method encompasses the creation of a healthy model,
the computation of a voxel-wise likelihood function as comparison between the healthy
model and the subject under examination, and the correction of the likelihood function
via prior distributions. The discriminant analysis is carried out to maximize the accuracy
of the classification. The algorithm has been trained on a dataset of 81 subjects and
achieved a sensitivity of 0.750 and a specificity of 0.875. Moreover, in accordance with
the current pathological knowledge, the parietal lobe, and limbic system are shown to
be the main discriminant factors.
Keywords: MRI, PASL, neuroimaging, Alzheimer’s disease, diagnosis
1. INTRODUCTION
Alzheimers disease (AD) is the most common cause of dementia. Symptoms include memory
loss, disturbances in language, psychological and psychiatric changes, and instabilities, as well as
impairment of daily life activities. Although, in recent years, many studies reported formation of
amyloid-beta peptide plaques in the brain of AD subjects, the underlying cause of AD is still mostly
unknown. Moreover, at the present day no efficient treatment is available. Some studies in the
past years reported a set of possible protective factors; however, none of them provided consistent
and sufficient evidence to be implemented as general health care standard (Burns and Iliffe, 2009;
Kawas, 2012; Salloway et al., 2014). The Alzheimers Association reported (Dementia, 2006) the
most common problems that early onset AD patients are confronted with: job performance, denied
employer assistance, and denied disability status. There are a variety of factors that might lead
to the aforementioned consequences, in particular the difficulty of getting an accurate and timely
diagnosis because of the unlikelihood of dementia in younger adults.
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There are a variety of diagnostic tools and methods being
used in clinical as well as medical practice. Most commonly,
neuropsychological tests, like theMini-Mental State Examination
(MMSE) (Pasquier, 1999), are used to assess memory disorders.
The most accurate method known for the diagnosis of AD
relies on the analysis of cerebrospinal fluid, reporting on average
a sensitivity >0.80 and a specificity >0.90 (Sjögren et al.,
2003). Despite the high accuracy, this method is highly invasive.
Neuroimaging techniques are also widely used in the diagnostic
process. In the standard diagnostic procedure, structural
magnetic resonance imaging (MRI) and functional [18F]-
Fluorodeoxyglucose Positron Emission Tomography (FDG-
PET) are used for the diagnosis of AD. FDG-PET is by far the best
established, most accurate single subject imaging method in the
diagnosis of AD. In particular, [18F]-Fluorodeoxyglucose is used
to assess abnormalities in the glucose metabolism in the brain.
Furthermore, there are specific PET tracers for visualization of
amyloid plaques such as [11C]-PiB which showed promising
results (Rinne et al., 2010). Currently, there are three officially
released amyloid-PET tracers: [18F]-Florbetaben (Piramal),
[18F]-Flutemetamol (GE Healthcare), and [18F]-Florbetapir (Eli
Lilly/AVID). These PET tracers are currently not broadly used
because of either limited distribution and/or restrictions in
reimbursement of amyloid PET examination (i.e., in Germany).
Structural MRI can be used for the detection of atrophy, in
particular of the hippocampus which is characteristic for AD.
However, hippocampal atrophy, according to the most accepted
hypothetical biomarker model in the pathophysiology of AD,
is a structural alteration which usually occurs later than AD-
typical FDG-hypometabolic alterations (i.e., in the Precuneus
and Posterior Cingulate Cortex). Alternatively, quantification of
regional cerebral blood flow (rCBF) is a promising method. rCBF
was found to be tightly correlated with the regional consumption
of glucose and reflects neuronal activity but SPECT and PET
based rCBF measurements also rely on radioactive tracers where
a number of restrictions apply (see Chetelat and Baron, 2003;
Ewers et al., 2011). A novel, absolutely non-invasive, MR based,
imaging technique, called arterial spin-labeling (ASL) might
represent a more convenient alternative. ASL is based on the
magnetic labeling of arterial water proton spins: inflowing blood
is labeled proximal to the tissue of interest, subsequently, brain
images are taken once the labeled blood reaches the brain.
Quantitative perfusion images are calculated from the difference
between labeled and unlabeled images (Detre et al., 1994).
One approach to explore the diagnostic potential of PASL is
the formulation of a quantitative diagnostic procedure, which
provides, at the same time, anatomical information. Thus,
the PASL based perfusion information can be reassured
by anatomical information in accordance with current
pathophysiological knowledge. Voxel-based morphometry
(VBM) is a statistical tool widely used to identify brain volume
differences between groups of subjects. At its simplest, this
method performs a series of voxel-wise comparisons revealing
regions which differ significantly between the two groups
(Friston et al., 1995). Although VBM is mostly used for
neuroscientific studies, diagnostic procedures based on VBM
are not novel in the literature. Most of these methods rely on a
custom voxel-wise computation of z-scores between the subject
under analysis and a model of the healthy population. A number
of successful results based on structural MRI have been reported
in Kawachi et al. (2006), Bonilha et al. (2009), Ishii et al. (2005),
Colliot et al. (2006), Hirata et al. (2005), and Mühlau et al.
(2009). For example, a diagnostic VBM procedure for Glioma
detection based on ASL images have been developed (Maumet
et al., 2013). More advanced methods relying on VBM have
also been proposed, such as classification of features computed
on brain regions (Zhang et al., 2008), or fuzzy classifications
(Thangaraj et al., 2010). There are several advantages for using
VBM. First of all, this method unfolds in a series of comparisons.
Compared to more complicated multivariate tools, it is simpler,
widely understood and accepted. Moreover, this method benefits
from a high level of anatomical information, which is given by
the intrinsic spatial information. The localization of significantly
different anatomical regions allows to control the quality,
meaningfulness, and interpretation of the results.
Our hypothesis is that the diagnosis of AD can be achieved
via PASL-based CBF images. In order to prove this, we propose
an adapted voxel-based probabilistic comparison method to
quantify abnormalities in individual AD patients based only on
PASL images. This method provides both quantitative results
of a standard computer-aided diagnostic procedure, and high
anatomical information of VBM.
2. MATERIALS AND METHODS
For the individual diagnosis of AD, we developed an adapted
VBM technique for the analysis of rCBF data. This adaptation
requires: (1) a CBFmodel of the healthy population, which will be
used as a reference for the comparison with an individual patient
(test-subject); (2) a voxel-wise comparison method between the
reference model and an individual subject, which will have to
classify each voxel of the test-subject as hypo-perfused (i.e., with
reduced perfusion) or normal (Alsop et al., 2010). The total
number of hypo-perfused voxels will represent the hypo-perfused
volume. Our assumption is that a correlation exists between
the hypo-perfused volume and the severity of the disease. From
this assumption, we strive to determine a discriminant number
of hypo-perfused voxels which allows to classify a patient as
diseased.Moreover, themethod has to take into account the noise
of the data and the fact that some hypo-perfusion can be caused
by other factors different from AD.
2.1. Subjects
We included 81 subjects in the study. In 54 patients and
32 healthy volunteers, a PASL sequence of the brain was
acquired. The patients were examined from 2011 to 2014 during
their clinical routine examinations for the clarification of their
symptoms of dementia. The healthy controls were recruited by
announcements in the clinic or relatives of the patients. They
had no subjective memory complaints and were independent in
their activities of daily living. The healthy controls and patients
have all been examined by a psychiatrist, five patients were
excluded from the study due to huge motion artifacts. None of
the healthy controls had to be excluded. The local institutional
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review board approved this single-center study. All patients gave
informed consent. The study was performed in accordance with
the ethical standards of the 1964 Declaration of Helsinki and its
later amendments (MAGA, 2004).
Each subject has been classified according to the diagnosis
established by a neuropsychiatrist: 32 healthy subjects were
included in the healthy cohort (HC). The remaining 49 patients
were diagnosed with AD: 19 early onset (ADEA) and 30
late onset (ADLA). Additionally, for each subject a set of
biomedical and cognitive measurements were acquired: age,
gender, MMSE score, and education (in years). We investigated
the correlations between the number of hypo-perfused voxels and
each biomedical and cognitive measurement.
2.2. Image Acquisition
Image acquisition was performed at 3T either on a Philips
Achieva System (Philips Healthcare, Hamburg, Germany) (n =
24) or on a Siemens mMR Biograph (Siemens Healthcare,
Erlangen, Germany) (n = 57). On both scanners, a similar
sequence and comparable imaging parameters were used. At
the Philips Achieva system, we used the pulsed star labeling of
arterial regions (PULSAR) technique (Golay et al., 2005), while
the proximal inversion with a control for off-resonance effects
(PICORE) labeling technique (Wong et al., 1999) was used at the
Siemens mMR Biograph. In both cases single shot EPI was used
for image readout with TR = 2500 ms, α = 90◦ and minimum
TE [TE = 17 ms (Philips); TE = 13 ms (Siemens)]. In both
cases thin slice periodic saturation pulses were used to obtain a
defined bolus (Q2TIPS) (Luh et al., 1999) using TI1, TI1S, TI2=
(700, 1200, 1500 ms). A set of eleven slices [matrix size 64 ×
63, voxel size of 3.75 × 3.75 × 6 mm (Philips) or 4 × 4 × 6
mm (Siemens), 0.6 mm gap] aligned to the hippocampus and
containing the parietal lobe were acquired in ascending order (see
Figure 1). Each measurement comprised eighty pairs of label-
control acquisitions. The total scan time was ∼440 s. In order
to perform a proper alignment between perfusion and structural
images, we acquired an EPI volume covering the whole brain with
the same voxel sizes in 40 slices, and a T1-weighted Turbo Field
Echo sequence with voxel size 1× 1× 1 mm in 170 sagittal slices.
2.3. Pre-Processing
We used a custom implementation written in MATLAB
(MathWorks, Natick, MA) and SPM5 (http://www.fil.ion.ucl.ac.
uk/spm) to perform spatial preprocessing and calculation of the
CBF-maps (see Preibisch et al., 2011 for details). In short, this
included the following steps: (1) realignment of the time series
of the control and tag images to correct for subject motion; (2)
computation of 80 difference images from pairs of registered
control and tag images; (3) computation of the average of the set
of difference images; (4) segmentation and registration of gray
matter (GM) and white matter (WM) probability maps to the
difference images; (5) computation of the CBF (Nöth et al., 2006;
Preibisch et al., 2011).
FIGURE 1 | Pulsed Arterial Spin-Labeling (PASL) scan region. (A) represents the bounding plane of the PASL signal coverage. (B) shows the coverage of the
PASL signal throughout the cohort. The intensity values represent the percentage of patients, who showed a non-zero pASL signal at that voxel location. All voxel
locations whose coverage was equal or less than 0.95 were discarded.
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To avoid the misinterpretation of brain atrophy as CBF
reduction, CBF values were corrected for partial volume effects
(Johnson et al., 2005; Preibisch et al., 2011). After correction
of CBF values, CBF maps were spatially normalized. Direct
utilization of CBF maps was not possible in this step, since they
show a low signal-to-noise ratio and few structural features.
Therefore, we co-registered the mean of all tag and control
images with the whole brain EPI reference image, which
was aligned to the T1-weighted image. Then, we applied the
same transformation to the CBF map. Finally, we spatially
normalized T1-weighted structural images and applied the same
transformation to CBF maps. The resulting CBF maps have a
voxel size of 2× 2× 2 mm, given by the interpolation procedure.
2.4. Post-Processing
The resulting CBF volumes are rather noisy because of the low
volume fraction (∼1–5%) of blood within tissue voxel. In order
to reduce possible harmful effects of the noise, we performed
a Gaussian smoothing procedure using different σ s and kernel
sizes s. We came to the conclusion that the best setting, i.e.,
providing the lowest classification error, was σ = 2 and s = 6.
Elderly subjects are more likely to be affected by
cardiovascular deficiencies, which might lead to a globally
reduced CBF. A globally reduced CBF, which is completely
uncorrelated to the Alzheimer condition, might hamper the
final diagnosis. Likewise, a systematic difference of labeling
efficiency between scanners might influence global CBF. In order
to mitigate the effects of age and related cardiovascular disorders
as well as systematic differences in labeling efficiency, a feature
scale normalization has been performed on each PASL volume.
Motion analysis has been done to evaluate the rotational and
translational movements of the participants. In order to avoid
false results, five patients had to be excluded from the study due
to their movements. These patients have already been excluded
in the description of the subjects in Section 2.1.
In order to simplify the computation, every volume In has
been linearized to the corresponding vector form Ŵn, where n is
the subject’s index. The inverse linearization procedure is then
applied to the results in order to obtain a volumetric image.
2.5. Model of the Healthy Population
In order to model the healthy population (i.e., reference
model), an element-wise univariate Gaussian approach has been
implemented by fitting a normal distribution in each voxel
location. This is achieved by computing the two parameters of
the distribution: mean µ and standard deviation σ (Equations
1a,b). This type of model is also known as moment driven, as
the model is based on the moments required by the distribution.
Leave-one-out cross-validation has been used during training.
This model is used in a probabilistic setting. Nonetheless, the very
same model is used for T-score estimation. The T-score estimate
allows the voxel-wise comparison between a healthy model and
a single subject. The final result provides an overview of the
structural or functional abnormalities carried by an individual.
We calculated the reference model with the healthy subjects (n=
32) and derived T-score maps for each individual subject for
visual comparison.
Ŵµ = N
−1
HC
∑
NHC
ŴHCn (1a)
Ŵσ = N
−1
HC(
∑
NHC
(ŴHCn − Ŵµ) ◦ (Ŵ
HC
n − Ŵµ))
◦1/2 (1b)
where ◦ is the Hadamard product, Ŵµ is the element-wise mean,
and Ŵσ is the element-wise standard deviation.
2.6. Voxel-Wise Comparison Method
2.6.1. Likelihood
In order to compare the model with an individual subject,
we used the complementary cumulative Gaussian distribution
and we computed the likelihood of deviant perfusion (Equation
2). The value represents a quantitative indicator of deviant
perfusion: values close to 1 identify a severe hypo-perfusion,
values close to 0.5 identify normal perfusion and values close to 0
identify hyper-perfusion.
Ln = 1−
∑
t ≤ Ŵn
N◦(t | Ŵµ, Ŵσ ) (2)
whereN◦ is the element-wise Gaussian density function.
The level of uncertainty in likelihood images is significant:
any voxel-wise difference in the CBF with the normal population
is classified as hypo- or hyper-perfused. In order to mitigate
the effects of this uncertainty, we applied a prior probability
distributions to the likelihood function (Equation 3, where M is
the number of prior distributions).
Pn = M
−1
∑
M
Ln ◦ πm (3)
2.6.2. First Prior
An expert knowledge can be used as prior information. In this
particular case, we know that values coming from the white
matter are unreliable (Deibler et al., 2008). Thus, the amount of
uncertainty can be reduced by removing non-gray matter signal
via a masking procedure. A voxel-wise probabilistic mask of the
gray matter (πGM) has been computed in the preprocessing step.
This procedure also removed the non-brain signal induced by the
smoothing procedure.
2.6.3. Second Prior
Different voxels might contribute differently to the final
prediction. In order to quantify the contribution of each voxel
location, ordinary least squares can be used (see Equation 4).
Xβ = y where β = (X−1X)/(X−1y) (4)
Let the matrix X be the matrix of observed variables, built by
stacking row vectors Ln. The response vector y is a vector of
dummy variables (i.e., each group is mapped to a numerical
identifier): HC → −1, and AD → 1. Thus, the vector β
represents the predictive contribution of each voxel location with
respect to the disease. This system of equations is not directly
solvable, as the number of features J is largely higher than the
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number of observed variables N. One way to overcome this
problem is Principal Component Analysis (PCA).In particular,
we applied a well-known PCAmethod for high-dimensional data
(Bishop and Nasrabadi, 2007). This is done by (1) evaluatingXXT
where X is the centered data matrix, (2) finding the eigenvalues
and eigenvectors (λj, vj) of N
−1XXT which are the same
eigenvalues and eigenvectors of the original (but computationally
infeasible) covariancematrix, and (3) computing the eigenvectors
of the original data space using uj = (Nλj)
−1/2XTvj. Notice
that we used only the first 20 components out of N available,
as they were providing the minimum misclassification error.
We reconstructed a reduced version of the original data
matrix X′ = XU by projection. Once the dimensionality of
the problem is reduced, we solved the linear system β ′ =
(X′−1X′)/(X′−1y) and obtained the values of the reduced β . Once
the vector of coefficients β ′ is found, we projected it onto the
principal components β = Uβ ′ to obtain the full-dimensional
approximation of β , which we used as second prior distribution
πPP. Each πPP obtained contains a value ranging from 0 to
1 which represents the predictive contribution of each voxel
location.
This procedure resulted in a predictive map (Figure 3D) for
each individual subject, which contains the values of the prior
distribution ranging from 0 to 1. A leave-one-out strategy was
used for training. Finally, we weighted the likelihood function
with prior distributions to produce corrected posterior images Pn
(Equation 3).
2.7. Discriminant Analysis
Each resultant posterior volume contains measures of cortical
perfusion whose deviations are correlated with the disease.
Diseased patients are expected to have severe hypo-perfusion,
or in other words, a high amount of voxels with low perfusion
values, most likely within the parietal and temporal lobe.
In order to be able to discriminate each single volume between
the two classes, we estimated the values of two thresholds: (1)
the Within Subject Threshold (tw), which is the discriminant
probability value to differentiate between a hypo-perfused voxel
and a normally perfused voxel; and (2) the Between Subjects
Threshold (tb): which is the number of voxels classified as hypo-
perfused in a volume, which functions as partition hyperplane
between the two classes. To determine both parameters we used
a discrete evaluation of the accuracy response to determine the
minimum misclassification rate. The corresponding sensitivity
and specificity responses were also estimated. A leave-one-out
strategy was used to compute the misclassification function
producing a pair of parameter values in every iteration .
This type of discriminant analysis provides a simple, visual
result. More advanced classification techniques can be used to
improve the accuracy. Among the methods proposed in the
machine learning literature, support vector machines (SVM)
(Cortes andVapnik, 1995) considered to be one of themost suited
techniques to handle high dimensional spaces. The principle of
SVM is to maximize the margin of the separation plane between
two classes. Kernel functions, such as the radial basis function,
can be used to handle non-linearly separable classes by projecting
the data to a higher dimensional space. We applied SVM with
radial basis kernels to the posterior probabilities returned by our
method.
2.8. Regional Analysis
In order to determine which brain regions were most affected by
hypo-perfusion, we analyzed the cerebral distribution of hypo-
perfused voxels using the Talairach brain atlas (Lancaster et al.,
2000). This procedure was carried out by simple segmentation
of each cerebral region for each subject, and accumulation of
the total value for each region across the subjects. Prior to
the segmentation procedure, every PASL volume has been co-
registered in the same coordinate system of the Talairach brain
template.
3. RESULTS
Subjects characteristics along with biomedical and cognitive
measurements are given in Table 1.
The constructed reference model of normal cerebral blood
perfusion, computed from the healthy group of subjects, is
shown in Figures 3A,B. The mean (µ) and standard deviation
(σ ) of healthy controls is shown, where high blood perfusion
(depicted in red) was mostly noticed in the parietal lobe and in
the cuneus, visible in the left and right hemisphere view. For
visual comparison, the CBF mean of the AD cohort is shown in
Figure 3C. Although the perfusion in the AD cohort conserves
a pattern similar to the one shown by the healthy perfusion,
large cerebral areas in the parietal lobe are visibly less perfused
compared to the mean of the healthy subjects (Figure 3A).
This observation is also confirmed by the prior distribution
built upon a regression model (Figure 2D) where the parietal
lobe and the surrounding regions evidenced a higher importance
for the prediction of AD. Figure 2 shows a comparison between
two randomly selected HC and AD subjects. Figures 2A,B
represent the CBF and the T-score, respectively. Figure 2C
shows the likelihood L using voxel-wise comparison. The healthy
individual showed low perfusion in the frontotemporal lobe,
which results from poor image quality due to susceptibility
artifacts in these areas. We could reduce this effect of uncertainty
in the likelihood images L by adding a prior distribution
(Figure 3D). In the posterior images (P) the areas with low
perfusion in healthy subjects have been suppressed, whereas
regions of hypo-perfusion in the parietal lobes of AD subject were
unaffected.
For the discriminant analysis we determined the following
thresholds: the within subject threshold tw, that is the probability
for which a voxel shall be considered diseased, equals to 0.86;
and the between subject threshold tb, which is the number of
voxels for which a subject shall be considered diseased, equals
to 200 (actually most of the runs in the testing phase produced
tb = 200 and tw = 0.86). In Figure 4 specificity, sensitivity
and misclassification functions for varying thresholds values are
plotted.
Utilizing this method, we achieved a sensitivity of 0.750 and a
specificity of 0.875 in the discrimination between healthy subjects
(HC) and AD patients (ADEA, ADLA). Training the model with
solely one subgroup of patients resulted in a sensitivity of
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FIGURE 2 | Comparison of one 75 years old patient with Alzheimers disease (AD) and one 68 years old healthy control (HC). (A) shows the normalized
CBF distribution, (B) shows the Tscore-map computed voxel-wise. A substantial difference could be already spotted in the parietal lobe. (C) shows the likelihood of
hypo-perfusion L. In the AD patient severely hypo-perfused areas in the parietal lobe and neighboring regions are visible, whereas the HC subject shows regions with
artificially low perfusion in the frontotemporal lobes and in the volume boundaries. These high values are the effect of uncertainty resulting from image noise, and/or
patient-specific conditions. (D) shows the posterior probability (p), which represents the disease related likelihood of hypo-perfusion resulting from the application of
the prior distribution. Areas with artificially low perfusion on volume boundaries have been suppressed, while the the sensitivity to interesting hypo-perfused region in
the parietal lobe is still preserved. Upper labels Rh, Cp, and Lh indicates right hemisphere, central posterior, and left hemisphere, respectively. Lateral labels Ex and In
indicates external view and internal view, respectively.
0.685 and specificity of 0.750 for the discrimination between
HC subjects and ADEA patients, and a sensitivity of 0.734
and specificity of 0.844 for the discrimination between HC
subjects and ADLA patients. The worsening of the classification
quality is given by the reduced cohort of diseased patients, and
the subsequent inability of the algorithm to properly model
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the disease. Finally, the application of SVM on the posterior
probabilities outperformed the thresholds based classification:
the resulting accuracy in the classification of HC vs AD was 0.9,
with a sensitivity of 1 and a specificity of 0.75.
With regional analysis we identified two distinct regions,
which contain almost all hypo-perfused voxels: the parietal and
temporal lobes, with particular focus on the limbic system,
TABLE 1 | Clinical subject characteristics (cognitive and biomedical
measurements) for each of the classification groups.
Category Age MMSE Education Gender
(years) (Female / Male)
ADLA 74.00 ± 6.70 21.93 ± 3.92 12.85 ± 3.95 15 / 15
ADEA 60.05 ± 6.38 22.35 ± 4.77 14.43 ± 4.50 10 / 9
HC 66.40 ± 6.19 29.46 ± 0.92 11.71 ± 3.24 22 / 10
which on average accounted for 49 and 11% of the hypo-
perfused voxels, respectively (Figure 5). We obtained significant
differences in the parietal (p < 0.0001) and the limbic system
(p = 0.0028).
The hypo-perfused volumes (i.e., the sum of hypo-perfused
voxels) can also be correlated with clinical data available from
each correctly classified patient. Particularly interesting is the
high inverse correlation between the hypo-perfused volume and
the MMSE score (ρ = −0.62, p < 0.001), which suggests the
validity of the results. The weak correlation between age and
hypo-perfusion (ρ = 0.32) can be explained by the characteristics
of the cohort: healthy subjects tended to be slightly younger than
patients. No correlation has been shown between hypo-perfusion
and education (ρ = 0.09), which confirms the current state of
the research (Burns and Iliffe, 2009; Kawas, 2012). APOE gene
correlations have not been included, as data were available only
for a few patients (see Table 1).
FIGURE 3 | Model of the cerebral blood perfusion based on HC subjects: (A) shows the mean and (B) the standard deviation of the healthy group. High
blood perfusion is visible in the parietal lobe and in the cuneus. We included for visual comparison (C), which shows the mean perfusion of the AD cohort. (D)
visualization of the prior distribution using principal component analysis to depict the predictive power of certain cerebral regions, where the parietal lobe showed the
highest predictive power.
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4. DISCUSSION
In the present study, we investigated the diagnostic potential of
PASL imaging in the diagnosis of AD. PASL offers two major
advantages compared to other perfusion techniques. First, since
PASL is an MR based method, the patient is not subjected
to ionizing radiation. Second the method does not use any
exogenous contrast agent and thus, is absolutely non-invasive.
Thereby the risk of allergic reactions can be avoided and even
patients with renal failure can be examined. This allows repeated
and reproducible measurements which are important for follow-
up studies. Several previous studies analyzed the CBF variations
in patients with AD on a group level. As initial investigation in
its diagnostic potential, we propose a method that provides both
quantitative and visual results. Specifically, we extended VBM
methodology, from a statistical tool modeling the differences
FIGURE 4 | Sensitivity, specificity, and misclassification rate functions. Discrete representation over varying threshold values. The x-axis (ranging from 0 to
5000) is associated with the Between Subject Threshold. The y-axes (ranging from 1 to 0.5) is associated with the Within Subject Threshold.
FIGURE 5 | Region Analysis. Group distributions of hypo-perfused voxels in the parietal (blue), temporal (orange), and limbic system (green). Lobes which were not
fully covered by the pASL signal have been excluded. Talairach brain atlas was used to perform the analysis.
Frontiers in Neuroscience | www.frontiersin.org 8 April 2016 | Volume 10 | Article 154
Trebeschi et al. Diagnostic Potential of PASL-MRI in AD
between groups, to a quantitative and visual diagnostic procedure
on a single subject level. This method encompasses the creation
of a likelihood model and the refinement of the probabilities
via prior distributions (i.e., predictive map) which account for
the low signal-to-noise ratio and the signal-disease correlation.
The comparison of the results of this method to other methods
commonly used in the medical community is shown in Figure 2.
Visual juxtaposition of rCBF maps (Figure 2A) or estimation
of T-Score maps (Figure 2B) are affected by a non negligible
amount of noise which makes it difficult to formulate a clear
diagnosis. Likelihoodmaps on the other hand (Figure 2C), might
already be capable of delineating some known characteristics
of the disease, like the hypoperfusion located in the parietal
lobe (Alsop et al., 2010). Nevertheless, the high variability
of the results still does not allow a clear formulation of
the diagnosis. The posterior distribution however (Figure 3D)
provides a clear evidence of the disease by highlighting the voxel
locations typically affected by disease related hypo-perfusion, and
facilitating in this way the whole diagnostic process. Specifically,
throughout the application of prior distributions, the likelihood
values in areas with high gray matter probability and high
disease-predictive power remain untouched. On the other hand,
likelihood values in areas with low gray matter probability
and/or low disease-predictive power will be down-weighted. This
visual result is reflected by the quantitative analysis, and the
high sensitivity and specificity. These outcomes have also been
proven to be inline with the current pathological knowledge
(Alsop et al., 2010): previous studies, in fact, reported hypo-
perfusion in the precuneus and parietal cortex (parietal lobe),
and the posterior cingulate (limbic system). In our results,
we observed two cerebral regions responsible for most of the
hypo-perfusion related to the disease: the parietal lobe and the
limbic system. Minor differences have also been detected in
the rest of the temporal lobe (see Figure 5). Furthermore, the
correlation between cognitive impairment and hypo-perfusion
volume suggests a possible link between them.
4.1. Limitations
The major limitation of this study is constituted by the cohort:
the number of healthy subjects and ADEA patients was relatively
limited which limits the accuracy of the normal perfusion model.
In addition to the size of the cohorts, also the age represents
a limitation of this study, as the healthy subjects tended to be
younger than diseased ones (p = 0.04) due to strict inclusion
criteria. Finally, the utilization of two different MRI scanners,
although both were using very similar settings, represents the last
cohort-related limitation of this study. A larger cohort, especially
with older healthy subjects and ADEA subjects, whose PASL
images have been acquired using the same scanner, might be
beneficial. From a purely medical point of view, no subjects
underwent examinations for the assessment of vascular diseases,
such as stenosis. To this end, one might want to perform
an analysis of the white matter lesions via Fazekas score or,
even better, analyze extra- and intracranial vessels via doppler
analysis or MR angiography to evaluate possible stenosis, which
might have an influence on CBF maps. Further limitations
are represented by the imaging modality: in order to obtain
quantitative CBF values, a number of influences need to be
considered (Deibler et al., 2008). For example, magnetically
labeled blood decays with T1 of 1500 ms at 3.0T and as a
result, sections acquired at last at the top of the volume will
have less label than those acquired at the bottom. Moreover, the
image acquisition process partially destroys the labeled spins and
the transit time of the labeled blood to the imaging site plays
an important role. In healthy subjects, the gray matter has a
transit time that can vary between 500 and 1500 ms, whereas in
deep white matter the transit time can be longer than 2000 ms
(Alsop et al., 2015). In patients, there might even be longer delays
due to vascular impairments which might result in an erroneous
quantification of the CBF in the affected brain regions. Despite
potential artifacts, the intrinsic non-invasiveness of PASL and
the tight correlation between cerebral blood flow and cerebral
activity make it a potentially attractive tool, worth to investigate
its diagnostic capability in AD. Furthermore, PASL images are
not covering the whole brain, but only a portion of it. Although
the portion of the brain covered by the signal is actually fully
covering those brain regions most affected by the disease, a full
coverage could improve the diagnostic accuracy. Furthermore, as
an MR based imaging technique, it encloses all contraindications
of standard MRI, like the impossibility of usage for subjects with
pacemakers and metal implants or claustrophobia.
4.2. Outlook
Recent pathophysiological studies (Verfaillie et al., 2015) also
reported PASL imaging to effectively identify other types of
dementia, like frontotemporal dementia. The application of
diagnostic procedures in these cases should produce similar
results as in Alzheimers dementia. Furthermore, better diagnostic
results might be obtained using pseudo-Continuous Arterial
Spin Labeling (pCASL), which is another MR based ASL
imaging technique but, unlike PASL, is able to acquire perfusion
images of the whole brain. Nonetheless, even if ASL is a
promising technique, ASL still needs further evaluation in order
to prove its clinical applicability. As significant variabilities can
occur in the perfusion pattern especially in the early stages
of the disease further examinations such as nuclear medicine
techniques are still needed for diagnostics at this stage. Therefore,
we are currently working on further analyze ASL, especially a
comparison with PET.
4.3. Conclusion
This study presents initial results obtained with computer aided
diagnostic (CAD) procedure for Arterial Spin Labeling (ASL)
images in AD. In spite of suboptimal ASL data quality and brain
coverage, this preliminary investigation showed good results and
suggests that PASL might be actually suited to assist individual
diagnosis of AD in the future, which principally opens a wide set
of opportunities for an early, non-invasive diagnosis of AD.
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